Non-Smad signaling pathways of the TGF-β family

Cold Spring Harbor Perspectives in Biology

Volumn 9, Issue 2, 2017, Pages

  Zhang, Ying E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL; HUMAN; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; GTP PHOSPHOHYDROLASES; HUMANS; PHOSPHORYLATION; PROTEIN KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 85011591309     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a022129     Document Type: Article

References (152)

1. Afrakhte M, Moren A, Jossan S, Itoh S, Sampath K, Westermark B, Heldin CH, Heldin NE, ten Dijke P. 1998. Induction of inhibitory Smad6 and Smad7 mRNA by TGFb family members. Biochem Biophys Res Commun 249: 505-511
2. Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, et al. 2003. Transient activation of NF-kB through a TAK1/ IKK kinase pathway by TGF-b1 inhibits AP-1/SMAD signaling and apoptosis: Implications in liver tumor formation. Oncogene 22: 412-425
3. Atfi A, Djelloul S, Chastre E, Davis R, Gespach C. 1997. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/ JNK) in transforming growth factor b-mediated signaling. J Biol Chem 272: 1429-1432
4. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor b-mediatedepithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810
5. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. 2002. p38 mitogen-activated protein kinase is required for TGFbmediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115: 3193-3206
6. Bandyopadhyay B, Han A, Dai J, Fan J, Li Y, Chen M, Woodley DT, Li W. 2011. TbRI/Alk5-independent TbRII signaling to ERK1/2 in human skin cells according to distinct levels of TbRII expression. J Cell Sci 124: 19-24.
7. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, et al. 2005. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307: 1621-1625
8. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. 2001a. Transforming growth factor-b1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12: 27-36
9. Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. 2001b. Integrin b1 signaling is necessary for transforming growth factor-b activation of p38MAPK and epithelial plasticity. J Biol Chem 276: 46707-46713
10. Boergermann JH, Kopf J, Yu PB, Knaus P. 2010. Dorsomorphin and LDN-193189 inhibitBMP-mediated Smad, p38 and Akt signalling in C2C12 cells. Intern J Biochem Cell Biol 42: 1802-1807
11. Bright JJ, Sriram S. 1998. TGF-b inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol 161: 1772-1777
12. Brown JD, DiChiara MR, Anderson KR, Gimbrone MA Jr, Topper JN. 1999. MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem 274: 8797-8805
13. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. 2008 The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8: 187-198
14. Chang SF, Chang TK, Peng HH, Yeh YT, Lee DY, Yeh CR, Zhou J, Cheng CK, Chang CA, Chiu JJ. 2009. BMP-4 induction of arrest and differentiation of osteoblast-like cells via p21 CIP1 and p27 KIP1 regulation. Mol Endocrinol 23: 1827-1838
15. Chen RH, Su YH, Chuang RL, Chang TY. 1998. Suppression of transforming growth factor-b-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene 17: 1959-1968
16. Conery AR, Cao Y, Thompson EA, TownsendCMJr, Ko TC, Luo K. 2004. Akt interacts directlywith Smad3 to regulate the sensitivity to TGF-b induced apoptosis. Nat Cell Biol 6: 366-372
17. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/ SAPK signaling pathway. Cell 81: 1137-1146
18. Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB. 2004. Imatinib mesylate inhibits the profibrogenic activity of TGF-b and prevents bleomycinmediated lung fibrosis. J Clin Invest 114: 1308-1316
19. Dees C, Tomcik M, Palumbo-Zerr K, Distler A, Beyer C, Lang V, Horn A, Zerr P, Zwerina J, Gelse K, et al. 2012. JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor b in systemic sclerosis. Arthritis Rheum 64: 3006-3015
20. Dey N, Ghosh-Choudhury N, Kasinath BS, Choudhury GG. 2012. TGFb-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion. PloS ONE 7: e42316
21. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. 2003. Distinct endocytic pathways regulate TGF-b receptor signalling and turnover. Nat Cell Biol 5: 410-421
22. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. Smurf1 interacts with transforming growth factor-b type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276: 12477-12480
23. Edlund S, Landström M, Heldin CH, Aspenström P. 2002. Transforming growth factor-b-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 13: 902-914
24. Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH, Landström M. 2003. Transforming growth factor-b1 (TGF-b)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-b-activated kinase 1 and mitogen-activated protein kinase kinase 3 Mol Biol Cell 14: 529-544
25. Edlund S, Landström M, Heldin CH, Aspenström P. 2004. Smad7 is required for TGF-b-induced activation of the small GTPase Cdc42. J Cell Sci 117: 1835-1847
26. Engel ME, McDonnell MA, Law BK, Moses HL. 1999 Interdependent SMAD and JNK signaling in transforming growth factor-b-mediated transcription. J Biol Chem 274: 37413-37420
27. Feng XH, Derynck R. 2005. Specificity and versatility in TGF-b signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693
28. Foletta VC, Lim MA, Soosairajah J, Kelly AP, Stanley EG, Shannon M, He W, Das S, Massagué J, Bernard O. 2003. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol 162: 1089-1098
29. Frey RS, Mulder KM. 1997. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/ Jun N-terminal kinase activation by transforming growth factor b in the negative growth control of breast cancer cells. Cancer Res 57: 628-633
30. Fruman DA, Rommel C. 2014. PI3K and cancer: Lessons, challenges and opportunities. Nat Rev Drug Discov 13: 140-156
31. Funaba M, Zimmerman CM, Mathews LS. 2002. Modulation of Smad2-mediated signaling by extracellular signalregulated kinase. J Biol Chem 277: 41361-41368
32. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, et al. 2001. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28: 491-498
33. Galliher AJ, Schiemann WP. 2007. Src phosphorylates Tyr284 in TGF-b type II receptor and regulates TGF-bstimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67: 3752-3758
34. Gamell C, Osses N, Bartrons R, Ruckle T, Camps M, Rosa JL, Ventura F. 2008. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J Cell Sci 121: 3960-3970.
35. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. 2002. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277: 33361-33368
36. Gingery A, Bradley EW, Pederson L, Ruan M, Horwood NJ, Oursler MJ. 2008. TGF-b coordinately activates TAK1/ MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res 314: 2725-2738
37. Gomis RR, Alarcon C, He W, Wang Q, Seoane J, Lash A, Massagué J. 2006. A FoxO-Smad synexpression group in human keratinocytes. Proc Natl Acad Sci 103: 12747-12752
38. Gudey SK, Sundar R, Mu Y, Wallenius A, Zang G, Bergh A, Heldin CH, Landström M. 2014. TRAF6 stimulates the tumor-promoting effects of TGFb type I receptor through polyubiquitination and activation of presenilin 1 Sci Signal 7: ra2
39. Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. 2008. Axin and GSK3-b control Smad3 protein stability and modulate TGF-b signaling. Genes Dev 22: 106-120
40. Ha H, Kwak HB, Le SW, Kim HH, Lee ZH. 2003a. Lipid rafts are important for the association of RANK and TRAF6 Exp Molec Med 35: 279-284
41. Ha H, Kwak HB, Lee SK, Na DS, Rudd CE, Lee ZH, Kim HH. 2003b. Membrane rafts play a crucial role in receptor activator of nuclear factor kB signaling and osteoclast function. J Biol Chem 278: 18573-18580
42. Haglund K, Dikic I. 2005. Ubiquitylation and cell signaling. EMBO J 24: 3353-3359
43. Hamidi A, von Bulow V, Hamidi R, Winssinger N, Barluenga S, Heldin CH, Landstrom M. 2012. Polyubiquitination of transforming growth factor b (TGFb)-associated kinase 1 mediates nuclear factor-kB activation in response to different inflammatory stimuli. J Biol Chem 287: 123-133
44. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K, Nishida E. 1999. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-b-induced gene expression. J Biol Chem 274: 27161-27167
45. Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S, Henis YI, Knaus P. 2006. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol 26: 7791-7805
46. Hayes S, Chawla A, Corvera S. 2002. TGFb receptor internalization into EEA1-enriched early endosomes: Role in signaling to Smad2. J Cell Biol 158: 1239-1249
47. Hocevar BA, Brown TL, Howe PH. 1999. TGF-b induces fibronectin synthesis through a c-Jun N-terminal kinasedependent, Smad4-independent pathway. EMBO J 18: 1345-1356
48. Hsu YL, Huang MS, Yang CJ, Hung JY, Wu LY, Kuo PL. 2011. Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway. J Biol Chem 286: 37335-37346
49. Hussey GS, Chaudhury A, Dawson AE, Lindner DJ, Knudsen CR, Wilce MC, Merrick WC, Howe PH. 2011. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. MolCell 41: 419-431
50. Inoue J, Gohda J, Akiyama T. 2007. Characteristics and biological functions of TRAF6 Adv ExpMed Biol 597: 72-79
51. Ishida W, Hamamoto T, Kusanagi K, Yagi K, Kawabata M, Takehara K, Sampath TK, Kato M, Miyazono K. 2000. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem 275: 6075-6079
52. Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P. 2003. Elucidation of Smad requirement in transforming growth factor-b type I receptor-induced responses. J Biol Chem 278: 3751-3761
53. Jadrich JL, O’Connor MB, Coucouvanis E. 2006 The TGFb activated kinase TAK1 regulates vascular development in vivo. Development 133: 1529-1541
54. Jaffe AB, Hall A. 2005 Rho GTPases: Biochemistry and biology. Annu Rev Cell Dev Biol 21: 247-269
55. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH. 2002. TGF-b induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol 4: 51-58
56. Javelaud D, Mauviel A. 2005. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-b: Implications for carcinogenesis. Oncogene 24: 5742-5750
57. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A, Larue L. 2007. Activation of NF-kB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26: 7445-7456
58. Jung SM, Lee JH, Park J, Oh YS, Lee SK, Park JS, Lee YS, Kim JH, Lee JY, Bae YS, et al. 2013. Smad6 inhibits non-canonical TGF-b1 signalling by recruiting the deubiquitinase A20 to TRAF6 Nat Commun 4: 2562
59. Kang MH, Oh SC, Lee HJ, Kang HN, Kim JL, Kim JS, Yoo YA. 2011.Metastatic function of BMP-2 in gastric cancer cells: The role of PI3K/AKT, MAPK, the NF-kB pathway, and MMP-9 expression. Exp Cell Res 317: 1746-1762
60. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, et al. 2009. TGF-b activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11: 881-889
61. Katsuno Y, Lamouille S, Derynck R. 2013. TGF-b signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25: 76-84
62. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFb receptor for degradation. Mol Cell 6: 1365-1375.
63. Kim KY, Kim BC, Xu Z, Kim SJ. 2004. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transformtransforming growth factor-b-induced apoptosis in hepatoma cells. J Biol Chem 279: 29478-29484
64. Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T. 2000. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 275: 17647-17652
65. Kretzschmar M, Doody J, Massagué J. 1997 Opposing BMP and EGF signalling pathways converge on the TGF-b family mediator Smad1. Nature 389: 618-622
66. Kretzschmar M, Doody J, Timokhina I, Massagué J. 1999. A mechanism of repression of TGFb/ Smad signaling by oncogenic Ras. Genes Dev 13: 804-816
67. Kua HY, Liu H, Leong WF, Li L, Jia D, Ma G, Hu Y, Wang X, Chau JF, Chen YG, et al. 2012. c-Abl promotes osteoblast expansion by differentially regulating canonical and noncanonical BMP pathways and p16INK4a expression. Nat Cell Biol 14: 727-737
68. Lai CF, Cheng SL. 2002. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-b in normal human osteoblastic cells. J Biol Chem 277: 15514-15522
69. Lamouille S, Derynck R. 2007. Cell size and invasion in TGF-b-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178: 437-451
70. Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. 2012. TGF-b-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci 125: 1259-1273
71. Lamouille S, Xu J, Derynck R. 2014.Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15: 178-196
72. Lawler S, Feng XH, Chen RH, Maruoka EM, Turck CW, Griswold-Prenner I, Derynck R. 1997. The type II transforming growth factor-b receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem 272: 14850-14859
73. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. TGF-b activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26: 3957-3967.
74. Lee-Hoeflich ST, Causing CG, Podkowa M, Zhao X, Wrana JL, Attisano L. 2004. Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. EMBO J 23: 4792-4801
75. Lehmann K, Janda E, Pierreux CE, Rytomaa M, Schulze A, McMahon M, Hill CS, Beug H, Downward J. 2000. Raf induces TGFb production while blocking its apoptotic but not invasive responses: A mechanism leading to increased malignancy in epithelial cells. Genes Dev 14: 2610-2622
76. Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, Provencher D, Mes-Masson AM. 2009. BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res 2: 4
77. Li Z, Fei T, Zhang J, Zhu G, Wang L, Lu D, Chi X, Teng Y, Hou N, Yang X, et al. 2012. BMP4 signaling acts via dualspecificity phosphatase 9 to control ERK activity in mouse embryonic stem cells. Cell Stem Cell 10: 171-182
78. Lim M, Chuong CM, Roy-Burman P. 2011. PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transi-tion (EMT) of PC-3 prostate cancer cells in 2-and 3-dimensional cultures. Horm Cancer 2: 298-309
79. Liu Y, Liu H, Meyer C, Li J, Nadalin S, Konigsrainer A, Weng H, Dooley S, ten Dijke P. 2013. Transforming growth factor-b (TGF-b)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation. J Biol Chem 288: 30708-30719
80. Massagué J. 2012. TGFb signalling in context. Nat Rev Mol Cell Biol 13: 616-630
81. Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G, Atfi A. 2001. Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J Biol Chem 276: 36797-36803.
82. McKay MM, Morrison DK. 2007. Integrating signals from RTKs to ERK/MAPK. Oncogene 26: 3113-3121
83. Minden A, Lin A, Claret FX, Abo A, Karin M. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81: 1147-1157
84. Miyazono K. 2008. Regulation of TGF-b family signaling by inhibitory Smads. In The TGF-b family (ed. Derynck R, Miyazono K), pp. 363-387 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
85. Moustakas A, Heldin CH. 2005.Non-Smad TGF-b signals. J Cell Sci 118: 3573-3584
86. Moustakas A, Heldin CH. 2012. Induction of epithelialmesenchymal transition by transforming growth factor b. Semin Cancer Biol 22: 446-454
87. Mu Y, Sundar R, Thakur N, Ekman M, Gudey SK, Yakymovych M, Hermansson A, Dimitriou H, Bengoechea-Alonso MT, Ericsson J, et al. 2011. TRAF6 ubiquitinates TGFb type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun 2: 330
88. Mulder KM, Morris SL. 1992. Activation of p21ras by transforming growth factor b in epithelial cells. J Biol Chem 267: 5029-5031
89. Muthusamy BP, Budi EH, Katsuno Y, Lee MK, Smith SM, Mirza AM, Akhurst RJ, Derynck R. 2015. ShcA protects against epithelial-mesenchymal transition through compartmentalized inhibition of TGF-b-induced Smad activation. PLoS Biol 13: e1002325
90. Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, Miyazono K, Taga T. 1999. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284: 479-482
91. Oakley FD, Smith RL, Engelhardt JF. 2009. Lipid rafts and caveolin-1 coordinate interleukin-1b (IL-1b)-dependent activation of NFkB by controlling endocytosis of Nox2 and IL-1b receptor 1 from the plasma membrane. J Biol Chem 284: 33255-33264
92. Olsson N, Piek E, Sundstrom M, ten Dijke P, Nilsson G. 2001. Transforming growth factor-b-mediated mast cell migration depends on mitogen-activated protein kinase activity. Cell Signal 13: 483-490
93. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. 2005. Regulation of the polarity protein Par6 by TGFb receptors controls epithelial cell plasticity. Science 307: 1603-1609
94. Remy I, Montmarquette A, Michnick SW. 2004. PKB/Akt modulates TGF-b signalling through a direct interaction with Smad3 Nat Cell Biol 6: 358-365
95. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S. 1999. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-b signaling. J Biol Chem 274: 8949-8957
96. Sapkota GP. 2013 The TGFb-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1 Open Biol 3: 130067
97. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massagué J. 2007 Balancing BMPsignaling through integrated inputs into the Smad1 linker. Mol Cell 25: 441-454
98. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225
99. Seoane J, Le HV, Shen L, Anderson SA, Massagué J. 2004. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211-223
100. Shapira KE, Hirschhorn T, Barzilay L, Smorodinsky NI, Henis YI, Ehrlich M. 2014. Dab2 inhibits the cholesteroldependent activation of JNK by TGF-b. Mol Biol Cell 25: 1620-1628
101. Shen X, Li J, Hu PP, Waddell D, Zhang J, Wang XF. 2001. The activity of guanine exchange factor NET1 is essential for transforming growth factor-b-mediated stress fiber formation. J Biol Chem 276: 15362-15368
102. Shi Y, Massagué J. 2003. Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 113: 685-700
103. Shibuya H, Iwata H, Masuyama N, Gotoh Y, Yamaguchi K, Irie K, Matsumoto K, Nishida E, Ueno N. 1998. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J 17: 1019-1028
104. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, et al. 2005. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19: 2668-2681
105. Shin I, Bakin AV, Rodeck U, Brunet A, Arteaga CL. 2001. Transforming growth factor b enhances epithelial cell survival via Akt-dependent regulation of FKHRL1 Mol Biol Cell 12: 3328-3339
106. Simeone DM, Zhang L, Graziano K, Nicke B, Pham T, Schaefer C, Logsdon CD. 2001. Smad4 mediates activation of mitogen-activated protein kinases by TGF-b in pancreatic acinar cells. Am J Physiol Cell Physiol 281: C311-C319
107. Song K, Wang H, Krebs TL, Danielpour D. 2006.Novel roles of Akt and mTOR in suppressing TGF-b/ALK5-mediated Smad3 activation. EMBO J 25: 58-69
108. Soong G, Reddy B, Sokol S, Adamo R, Prince A. 2004. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 113: 1482-1489
109. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landström M. 2008. The type I TGF-b receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10: 1199-1207
110. Takaesu G, Surabhi RM, Park KJ, Ninomiya-Tsuji J, Matsumoto K, Gaynor RB. 2003. TAK1 is critical for IkB kinase-mediated activation of the NF-kB pathway. J Mol Biol 326: 105-115
111. Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, Saito H. 2002. Smad-dependent GADD45b expression mediates delayed activation of p38 MAP kinase by TGF-b. EMBO J 21: 6473-6482
112. Tang Y, Kitisin K, Jogunoori W, Li C, Deng CX, Mueller SC, Ressom HW, Rashid A, He AR, Mendelson JS, et al. 2008. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-b and IL-6 signaling. Proc Natl Acad Sci 105: 2445-2450
113. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. 1998. SARA, a FYVE domain protein that recruits Smad2 to the TGFb receptor. Cell 95: 779-791.
114. Valderrama-Carvajal H, Cocolakis E, Lacerte A, Lee EH, Krystal G, Ali S, Lebrun JJ. 2002. Activin/TGF-b induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol 4: 963-969
115. Vinals F, Pouysségur J. 2001. Transforming growth factor b1 (TGF-b1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-a signaling. Mol Cell Biol 21: 7218-7230
116. Voorneveld PW, Kodach LL, Jacobs RJ, Liv N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes DW, de Rooij K, et al. 2014. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK. Gastroenterology 147: 196-208
117. Wang L, Zhu Y, Sharma K. 1998. Transforming growth factor-b1 stimulates protein kinase A in mesangial cells. J Biol Chem 273: 8522-8527
118. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. 2001. TAK1 is a ubiquitin-dependent kinase of MKKand IKK. Nature 412: 346-351
119. Wang S, Wilkes MC, Leof EB, Hirschberg R. 2005. Imatinib mesylate blocks a non-Smad TGF-b pathway and reduces renal fibrogenesis in vivo. FASEB J 19: 1-11
120. Wang YK, Yu X, Cohen DM, Wozniak MA, Yang MT, Gao L, Eyckmans J, Chen CS. 2012. Bone morphogenetic protein-2-induced signaling and osteogenesis is regulated by cell shape, RhoA/ROCK, and cytoskeletal tension. Stem Cells Dev 21: 1176-1186
121. Weston CR, Davis RJ. 2007 The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149
122. Wierenga AT, Schuringa JJ, Eggen BJ, Kruijer W, Vellenga E. 2002. Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-b1 is mediated by caspase-dependent and-independent processes. Leukemia 16: 675-682
123. Wilkes MC, Murphy SJ, Garamszegi N, Leof EB. 2003. Celltype-specific activation of PAK2 by transforming growth factor b independent of Smad2 and Smad3 Mol Cell Biol 23: 8878-8889
124. Wilkes MC, Mitchell H, Penheiter SG, Dore JJ, Suzuki K, Edens M, Sharma DK, Pagano RE, Leof EB. 2005. Transforming growth factor-b activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2 Cancer Res 65: 10431-10440
125. Wong WK, Knowles JA, Morse JH. 2005. Bone morphogenetic protein receptor type II C-terminus interacts withc-Src: Implication for a role in pulmonary arterial hypertension. Am J Respir Cell Molec Biol 33: 438-446
126. Wu H, Arron JR. 2003. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. BioEssays 25: 1096-1105
127. Wu MY, Hill CS. 2009. TGF-b superfamily signaling in embryonic development and homeostasis. Dev Cell 16: 329-343
128. Xia H, Ooi LL, Hui KM. 2013. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology 58: 629-641
129. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL. 2004. Activation of the Erk pathway is required for TGFb1-induced EMT in vitro. Neoplasia 6: 603-610
130. Xue G, Restuccia DF, Lan Q, Hynx D, Dirnhofer S, Hess D, Ruegg C, Hemmings BA. 2012. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-b signaling axes. Cancer Discov 2: 248-259
131. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-b signal transduction. Science 270: 2008-2011
132. Yamamoto T, Matsuda T, Muraguchi A, Miyazono K, Kawabata M. 2001. Cross-talk between IL-6 and TGF-b signaling in hepatoma cells. FEBS Lett 492: 247-253
133. Yamamura Y, Hua X, Bergelson S, Lodish HF. 2000. Critical role of Smads and AP-1 complex in transforming growth factor-b-dependent apoptosis. J Biol Chem 275: 36295-36302
134. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE. 2008. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-b. Mol Cell 31: 918-924
135. Yan Z, Winawer S, Friedman E. 1994. Two different signal transduction pathways can be activated by transforming growth factor b1 in epithelial cells. J Biol Chem 269: 13231-13237
136. Yanagisawa M, Nakashima K, Takeda K, Ochiai W, Takizawa T, Ueno M, Takizawa M, Shibuya H, Taga T. 2001. Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7 Genes Cells 6: 1091-1099
137. Yang YA, Zhang GM, Feigenbaum L, Zhang YE. 2006. Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2 Cancer Cell 9: 445-457
138. Yang WL, Wang J, Chan CH, Lee SW, Campos AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG, et al. 2009 The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325: 1134-1138
139. Yi JY, Shin I, Arteaga CL. 2005 Type I transforming growth factor b receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 280: 10870-10876
140. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ Jr, Liebermann DA, Böttinger EP, Roberts AB. 2003. Transforming growth factor-b-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem 278: 43001-43007
141. Yoon S, Seger R. 2006. The extracellular signal-regulated kinase:Multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44
142. Yu L, Hebert MC, Zhang YE. 2002. TGF-b receptor-activated p38 MAP kinase mediates Smad-independent TGF-b responses. EMBO J 21: 3749-3759
143. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP. 2001. Genetic programs of epithelial cell plasticity directed by transforming growth factor-b. Proc Natl Acad Sci 98: 6686-6691
144. Zhang YE. 2009. Non-Smad pathways in TGF-b signaling. Cell Res 19: 128-139
145. Zhang L, Wang W, Hayashi Y, Jester JV, Birk DE, Gao M, Liu CY, Kao WW, Karin M, Xia Y. 2003. A role forMEKkinase 1 in TGF-b/activin-induced epithelium movement and embryonic eyelid closure. EMBO J 22: 4443-4454
146. Zhang L, Duan CJ, Binkley C, Li G, Uhler MD, Logsdon CD, Simeone DM. 2004. A transforming growth factor b-induced Smad3/Smad4 complex directly activates protein kinase A. Mol Cell Biol 24: 2169-2180
147. Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu CX, et al. 2012. USP4 is regulated by Akt phosphorylation anddirectly deubiquitylates TGF-b type I receptor. Nat Cell Biol 14: 717-726
148. Zhang L, Zhou F, Garcia de Vinuesa A, de Kruijf EM, Mesker WE, Hui L, Drabsch Y, Li Y, Bauer A, Rousseau A, et al. 2013. TRAF4 promotes TGF-b receptor signaling and drives breast cancer metastasis. Mol Cell 51: 559-572
149. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. 2004. Dual regulation of Snail by GSK-3b-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6: 931-940
150. Zhou Q, Heinke J, Vargas A, Winnik S, Krauss T, Bode C, Patterson C, Moser M. 2007. ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc Res 76: 390-399
151. Zhou Z, Xie J, Lee D, Liu Y, Jung J, Zhou L, Xiong S, Mei L, Xiong WC. 2010. Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation. Dev Cell 19: 90-102
152. Zuo W, Chen YG. 2009. Specific activation of mitogen-activated protein kinase by transforming growth factor-b receptors in lipid rafts is required for epithelial cell plasticity. Mol Biol Cell 20: 1020-1029.